Colonial Trust’s GSK GSK Stock Holding History

Colonial Trust’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$52.4K	Sell	1,000 -7,000	-88%	-$370K	0.01%	515
2026 Q1	$442K	Sell	8,000 -33	-0.4%	-$1.79K	0.06%	194
2025 Q4	$394K	Sell	8,033 -12	-0.1%	-$560	0.05%	211
2025 Q3	$347K	Sell	8,045 -1	-0%	-$39	0.05%	234
2025 Q2	$309K	Buy	8,046 +46	+0.6%	+$1.76K	0.05%	242
2025 Q1	$310K	Sell	8,000 -300	-4%	-$11K	0.05%	222
2024 Q4	$281K	Sell	8,300 -181	-2%	-$6.52K	0.04%	244
2024 Q3	$347K	Hold	8,481	–	–	0.05%	217
2024 Q2	$327K	Hold	8,481	–	–	0.06%	200
2024 Q1	$364K	Sell	8,481 -950	-10%	-$39.2K	0.07%	183
2023 Q4	$350K	Buy	9,431 +2,000	+27%	+$71.8K	0.07%	181
2023 Q3	$269K	Buy	7,431 +200	+3%	+$7.1K	0.07%	192
2023 Q2	$258K	Buy	7,231 +3,050	+73%	+$109K	0.06%	195
2023 Q1	$149K	Buy	4,181 +4,000	+2,210%	+$140K	0.04%	272
2022 Q4	$6.36K	Buy	+181	New	+$6.03K	﹤0.01%	722

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Colonial Trust's GSK Position: Q2 2026 in Review

Colonial Trust reduced its GSK (GSK) stake by 88% in Q2 2026, selling an estimated $370K and leaving 1,000 shares worth $52.4K. The position accounts for 0.01% of the portfolio, ranked #515.

Colonial Trust first reported a position in GSK in Q4 2022 and has held it in 15 quarters since. The position peaked at $442K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Colonial Trust held 1,000 shares of GSK worth $52.4K as of Q2 2026.
Colonial Trust sold 7,000 GSK shares in Q2 2026, an estimated $370K.
GSK made up 0.01% of Colonial Trust's portfolio in Q2 2026, its #515 holding.
Colonial Trust first reported a position in GSK in Q4 2022 and has held it in 15 quarters since.
Colonial Trust's GSK position peaked at $442K in Q1 2026.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Colonial Trust's 13F filing for Q2 2026, filed 11 Aug 2026.